Negotiating excess treatment costs in a clinical research trial: the good, the bad and the innovative. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Palmer, Rebecca; Harrison, Madeleine; Cross, Elizabeth; Enderby, Pam
• Is Part Of: Trials. Volume 17:Issue 1(2016)
• Page Start: 1
• Page End: 3
• Publication Date: 2016-12
• Subjects: Excess treatment costs -- Clinical trials -- Trial set up; Group-randomized trials -- Periodicals; Randomized Controlled Trials -- Periodicals; 615.0727
• DOI: 10.1186/s13063-016-1208-5
• Languages: English
• ISSNs: 1745-6215

Abstract

Abstract Barriers to recovering the excess treatment costs associated with health research from local organisations in the United Kingdom can increase research costs, delay completion of high- quality studies and risk disenfranchising health trusts and patients from participation. The authors demonstrate how the process for recovering excess treatment costs at a local National Health Service (NHS) trust level in a multicentre study was inconsistent and resulted in excess effort and cost to the research budget. An innovative example of how an organisation acting as a broker between commissioners and researchers facilitated a more timely excess treatment cost agreement is highlighted. Trial registration Current Controlled TrialsISRCTN68798818, registered on 18 February 2014.